Major phytocannabinoids and their related compounds: should we only search for drugs that act on cannabinoid receptors? LE Filipiuc, DC Ababei, T Alexa-Stratulat, CV Pricope, V Bild, ... Pharmaceutics 13 (11), 1823, 2021 | 48 | 2021 |
Systemic actions of sglt2 inhibition on chronic mtor activation as a shared pathogenic mechanism between alzheimer’s disease and diabetes GD Stanciu, RN Rusu, V Bild, LE Filipiuc, BI Tamba, DC Ababei Biomedicines 9 (5), 576, 2021 | 27 | 2021 |
The Skin and Natural Cannabinoids–Topical and Transdermal Applications SI Filipiuc, AN Neagu, CM Uritu, BI Tamba, LE Filipiuc, IM Tudorancea, ... Pharmaceuticals 16 (7), 1049, 2023 | 8 | 2023 |
Should oncologists trust cannabinoids? I Creanga-Murariu, LE Filipiuc, M Cuciureanu, BI Tamba, T Alexa-Stratulat Frontiers in Pharmacology 14, 1211506, 2023 | 5 | 2023 |
Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in Rodents LE Filipiuc, R Ştefănescu, C Solcan, M Ciorpac, A Szilagyi, D Cojocaru, ... Pharmaceuticals 16 (5), 694, 2023 | 3 | 2023 |
The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth I Creanga-Murariu, LE Filipiuc, MR Gogu, M Ciorpac, CM Cumpat, ... Frontiers in Pharmacology 15, 1395951, 2024 | | 2024 |
B393 Acute toxicity assessment for three synthetic cannabinoids with potential for action in chronic neuropathic pain LE Filipiuc, GD Stanciu, DC Ababei, CT Mihai, CV Pricope, CC Caratasu, ... Regional Anesthesia & Pain Medicine 47 (Suppl 1), A271-A271, 2022 | | 2022 |